(Q57611798)
Statements
Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study (English)
R Schnabel
AtheroGene Investigators
M C Alessi
T Godefroy
V Nicaud
T Munzel
C Bickel
H J Rupprecht
E Lubos
T Zeller
I Juhan-Vague
S Blankenberg
L Tiret